Le Tourneau, C., Paoletti, X., Servant, N., Bièche, I., Gentien, D., Rio Frio, T., . . . Kamal, M. (2014). Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: Results of the feasibility part of the SHIVA trial. Nature Publishing Group.
Chicago ZitierstilLe Tourneau, C., et al. Randomised Proof-of-concept Phase II Trial Comparing Targeted Therapy Based On Tumour Molecular Profiling Vs Conventional Therapy in Patients With Refractory Cancer: Results of the Feasibility Part of the SHIVA Trial. Nature Publishing Group, 2014.
MLA ZitierstilLe Tourneau, C., et al. Randomised Proof-of-concept Phase II Trial Comparing Targeted Therapy Based On Tumour Molecular Profiling Vs Conventional Therapy in Patients With Refractory Cancer: Results of the Feasibility Part of the SHIVA Trial. Nature Publishing Group, 2014.